Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
about
Host-guest inclusion system of scutellarein with 2-hydroxypropyl-beta-cyclodextrin: preparation, characterization, and anticancer activity.Characterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781Production and characterization of a spray-dried hydroxypropyl-beta-cyclodextrin/quercetin complex.Characterization of cimetidine-piroxicam coprecipitate interaction using experimental studies and molecular dynamic simulations.Exploring therapeutic potentials of baicalin and its aglycone baicalein for hematological malignanciesComparison of spray freeze drying and the solvent evaporation method for preparing solid dispersions of baicalein with Pluronic F68 to improve dissolution and oral bioavailability.Baicalein selectively induces apoptosis in activated lymphocytes and ameliorates concanavalin a-induced hepatitis in mice.A promising antitumor activity of evodiamine incorporated in hydroxypropyl-β-cyclodextrin: pro-apoptotic activity in human hepatoma HepG2 cells.Changes in the intestinal absorption mechanism of icariin in the nanocavities of cyclodextrins.The formation of a host-guest inclusion complex system between β-cyclodextrin and baicalin and its dissolution characteristics.Development of imiquimod-loaded mucoadhesive films for oral dysplasia.The influence of postharvest processing and storage of foodstuffs on the bioavailability of flavonoids and phenolic acids.Interactions between polyphenols and macromolecules: quantification methods and mechanisms.Pharmaceutical properties and toxicology of Dioclea grandiflora.Pharmacokinetics of cyclodextrins and drugs after oral and parenteral administration of drug/cyclodextrin complexes.Anticancer properties of baicalein: a review.Application of carrier and plasticizer to improve the dissolution and bioavailability of poorly water-soluble baicalein by hot melt extrusion.Preparation, Characterization and Pharmacokinetic Study of Xiangfu Siwu Decoction Essential Oil/β-Cyclodextrin Inclusion Complex.Parenteral delivery of HPβCD: effects on drug-HSA binding.Preparation, characterization, and pharmacokinetics of the inclusion complex of genipin-beta-cyclodextrin.Dissolution and pharmacokinetics of baicalin-polyvinylpyrrolidone coprecipitate.Long-circulating nanoliposomes (LCNs) sustained delivery of baicalein (BAI) with desired oral bioavailability in vivo.Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.A novel matrix dispersion based on phospholipid complex for improving oral bioavailability of baicalein: preparation, in vitro and in vivo evaluations.Liquid chromatography-tandem mass spectroscopic method for the determination of zerumbone in human plasma and its application to pharmacokinetics.
P2860
Q30761040-D7B2EADB-6CF7-4F12-84BD-CE76DC258D66Q33393733-C7089306-B3C2-4369-8DC4-5022B1279890Q33465236-211C91E9-32EE-43A3-AA8B-2D8A936F7F42Q33590757-3324C326-A8FB-4C99-AF17-4D4E5E444EDEQ34266506-391E5782-2C67-41FB-9831-367FD1A3BCE8Q34733861-193CFE3F-014B-4468-890A-9EF749C13955Q34874016-4EF39F91-DE9E-4A85-81F9-02F7C1219E04Q36085681-435744B7-9250-44F9-848E-3614CB80127AQ36161028-ED1DCE46-DE91-4AFB-9F69-8BFC0E1BD77EQ36310011-529248BC-EA53-4E5D-BF84-1E27904A3B87Q36914702-73AEBF06-7AD8-4B19-A3E2-C7603384AAE5Q37335364-083552E8-721C-45C4-94F8-5BB89217FCB8Q37972915-A00B5276-99D4-42A3-B5E1-B1A760CE13B3Q38078046-23E255DB-3219-4CDD-80FD-3A9FF337AB07Q38522903-95ACB18B-A8F7-4B63-9D89-1275B454BC2CQ39051133-2C37219F-0A99-4541-98D5-A8C767A46DDCQ40027531-FD3DB39A-CEA7-4759-9066-401C68F67B1DQ40845200-BEEC9393-78F1-4B17-96CA-C7B83C790257Q41898234-9E9AA836-A185-4A41-AAE2-79FCE43DFE7AQ43237804-525F66DC-3F1F-4891-9B5A-C2F17CA7D4D5Q44818683-C5858D4F-CFF7-49C9-8966-2F12C77727E2Q45692707-5041D03B-EE33-4A6A-A2E0-78C9B44E205AQ46047616-6FE3A89F-5C65-4BCD-A654-93F0957E05E2Q50653719-7B92680F-1313-48AA-A886-1F7A175E1A72Q53087795-C17FC295-4E2A-4284-812B-A798794D721D
P2860
Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Preparation, characterization ...... droxypropyl-beta-cyclodextrin.
@en
Preparation, characterization ...... droxypropyl-beta-cyclodextrin.
@nl
type
label
Preparation, characterization ...... droxypropyl-beta-cyclodextrin.
@en
Preparation, characterization ...... droxypropyl-beta-cyclodextrin.
@nl
prefLabel
Preparation, characterization ...... droxypropyl-beta-cyclodextrin.
@en
Preparation, characterization ...... droxypropyl-beta-cyclodextrin.
@nl
P2093
P1476
Preparation, characterization ...... droxypropyl-beta-cyclodextrin.
@en
P2093
P304
P356
10.1016/J.IJPHARM.2006.01.011
P407
P577
2006-02-03T00:00:00Z